The dark side of platelet glycoprotein IIb/IIIa receptor inhibitors during percutaneous coronary interventions.
Lloyd W
LW
Klein
James E
JE
Calvin
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000379:methods*; D002986:Clinical Trials as Topic / Q000592:standards; D003327:Coronary Disease / Q000628:therapy*; D006801:Humans; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D012042:Registries; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
D019039:Platelet Glycoprotein GPIIb-IIIa Complex